Records containing: Hodgkin's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-09-28A Current Practice Study of Rituxan in Patient Receiving BEAM Chemotherapy and Autologous Blood Stem Cell Transplantation for High Risk Lymphoma or Hodgkin's Disease
-
CLINICAL_TRIALS study record update · 2015-07-10A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy
-
CLINICAL_TRIALS study record update · 2015-06-22Phase 1 Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy
-
CLINICAL_TRIALS study record update · 2015-03-24Expanded Acess Study of Plerixafor and G-CSF for the Mobilization and Collection of Peripheral Blood Stem Cells for Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease or Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2015-03-10Phase I Study of Vorinostat in Combination With Niacinamide, and Etoposide for the Treatment of Patients With Relapsed and Refractory Lymphoid Malignancies
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-01-08ClinicalTrials.gov study NCT01458288
-
CLINICAL_TRIALS study record update · 2014-10-13A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies in Remission From HLA Partially-Matched Related Donors
-
CLINICAL_TRIALS study record update · 2014-09-11Investigation of the Cylex® ImmuKnow® Assay
-
CLINICAL_TRIALS study record update · 2014-07-09A Feasibility Study of Tamoxifen Prevention of Breast Cancer in Hodgkin's Disease Survivors
-
CLINICAL_TRIALS study record update · 2014-06-10A Phase II Study to Investigate the Efficacy of Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2014-06-02Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2014-05-16Total Body Irradiation With Fludarabine Conditioning Followed by Transplantation With Combined Umbilical Cord Blood Grafts
-
CLINICAL_TRIALS study record update · 2014-03-31T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2014-03-26Prospective, Open-label, Multicentre Clinical Trial, Phase I/IIa, to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates CD3+-Depleted, CD19+-Enriched, Cryopreserved (Single Administration After Day 120 Following Allogeneic Stem Cell Transplantation (SCT), Donor-identical) in 4 Groups With Escalating Doses for Immune Response Enhancement, Measured as Response to a Antedated Single Vaccination
-
CLINICAL_TRIALS study record update · 2014-02-11A Multicenter, Randomized, Comparative, Patient-blinded Study to Evaluate the Safety and Efficacy of G-CSF Alone Versus AMD3100 (240 µg/kg) Added to a G-CSF Mobilization Regimen in Adult Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkins Disease (HD) or Multiple Myeloma (MM) Who Have Previously Failed Stem Cell Collections or Collection Attempts
-
CLINICAL_TRIALS study record update · 2013-10-17A Phase 1, Open-Label, Multi-Center, Parallel Group Study to the Pharmacokinetics and Safety of Subcutaneous Azacitidine in Adult Cancer Patients With and Without Impaired Renal Function
-
CLINICAL_TRIALS study record update · 2013-08-28A Phase I Trial Using Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-07-03Whole-body MR Imaging for Staging Malignant Lymphomas
-
CLINICAL_TRIALS study record update · 2013-03-14Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2012-12-20A Prospective Study of Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy With or Without Mediastinal Irradiation
-
CLINICAL_TRIALS study record update · 2012-08-23CD8 Depleted Donor Lymphocyte Infusions for Patients With Relapse Or Residual Disease Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-08-01Psychosocial Impact of Cancer-Related Female Infertility
-
CLINICAL_TRIALS study record update · 2012-03-20In-Vivo Activated T-Cell Depletion to Prevent GVHD
-
CLINICAL_TRIALS study record update · 2012-01-26Open Label Phase II Trial of Sirolimus in Combination With Tacrolimus for Graft-vs-Host Disease Prophylaxis After HLA-Matched, Unrelated, Allogeneic Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2012-01-26Open Label Phase II Trial of Sirolimus in Combination With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Matched, Related Allogeneic Hematopoietic Stem Cell Transplantation